Profile
GCTK ISRG BDXA BDX ALC RMD
Company Name GlucoTrack, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $3.73M $173.19B $53.11B $49.57B $43.46B $40.72B
Employees 0.01K 15.64K 0.00K 70.00K 25.60K 9.98K
CEO Paul V. Goode Gary S. Guthart - Thomas E. Polen Jr. David J. Endicott Michael J. Farrell BE, MBA, SM
Ratings
GCTK ISRG BDXA BDX ALC RMD
Quant Rating Score 3 1 5 3 3 4
Quant Rating Neutral Strong Sell Strong Buy Neutral Neutral Buy
Trading
GCTK ISRG BDXA BDX ALC RMD
Last Close $6.23 $483.12 $59.24 $176.37 $87.87 $279.2
High 52 $8.29 $610.45 $59.24 $249.08 $100.76 $279.2
Low 52 $0.06 $438 $59.24 $165.15 $82.73 $204.58
Price vs. 52 Week High -24.85 % -20.86 % 0 % -29.19 % -12.79 % 0 %
Price vs. 52 Week Low 10283.3 % 10.3 % 0 % 6.79 % 6.21 % 36.47 %
Total Return
GCTK ISRG BDXA BDX ALC RMD
1 Month Return -5.89 % -11.27 % 0 % 0.12 % 0.1 % 8.66 %
3 Month Return 3592.95 % -8.75 % 0 % 4.5 % -10.61 % 16.36 %
6 Month Return 10829.8 % -16.49 % 0 % -28.77 % -2.8 % 16.07 %
9 Month Return 258.05 % -4.59 % 0 % -25.03 % -4.27 % 14.3 %
YTD Return 1570.24 % -7.44 % 0 % -22.26 % 3.51 % 22.09 %
1 Year Return 358.09 % 7.42 % 0 % -27.08 % -4.88 % 24.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
GCTK ISRG BDXA BDX ALC RMD
Dividend Yield Percentage (TTM) - - 2.28 % 2.35 % 0.38 % 0.76 %
Dividend Paid and Capex Coverage Ration (TTM) -231.24 % 2.77 % 1.77 % 1.77 % 3.43 % 4.21 %
Dividend Per Share (TTM) - - 4.07 % 4.07 % 0.33 % 2.12 %
Payout Ratio (TTM) - - 76.77 % 76.77 % 11.23 % 23.14 %
Growth
GCTK ISRG BDXA BDX ALC RMD
Asset Growth 20.94 % 21.38 % 8.54 % 8.54 % 1.79 %
Gross Profit Growth 100 % 19.13 % 11.69 % 11.69 % 12.72 %
Revenue Growth - 17.24 % 4.16 % 4.16 % 10.95 %
Revenue 3 Year - 46.64 % -0.51 % -0.51 % 44.86 %
Revenue 5 Year -100 % 81.77 % 8.72 % 8.72 % 74.97 %
Revenue 10 Year - 266.32 % 59.37 % 59.37 % 189.94 %
EBIT Growth -209.88 % 32.95 % 19.82 % 19.82 % 12.75 %
Net Income Growth 418.4 % 29.18 % 14.89 % 14.89 % 13.75 %
Net Income 3 Yeari Growth Per Share 328.22 % 36.6 % -18.63 % -18.63 % 112.66 %
Net Income 5 Yeari Growth Per Share 305.63 % 64.12 % 30.19 % 30.19 % 145.63 %
Net Income 10 Yeari Growth Per Share - 418.52 % -4.02 % -4.02 % 184.54 %
Operating Income Growth -104.77 % 32.95 % 13.55 % 13.55 % 16.61 %
Operating Cash Flow Growth (CFG) -90.45 % 33.15 % 27.07 % 27.07 % 102.11 %
Operating 3 Year CFG -37.22 % 15.88 % -18.4 % -18.4 % 87.99 %
Operating 5 Year CFG -2.5 % 47.28 % 6.25 % 6.25 % 197.13 %
Operating 10 Year CFG - 239.49 % 45.28 % 45.28 % 244.62 %
EPS Growth 258.64 % 27.71 % 18.31 % 18.31 % 13.4 %
EPS Diluted Growth 258.64 % 27.63 % 18.62 % 18.62 % 13.63 %
Book Value Per Share -302.27 % 21.99 % -0.85 % -0.85 % 17.57 %
Share Holder 3 Year Equity Growth Per Share -204.42 % 37.85 % 9.16 % 9.16 % 66.6 %
Share Holder 5 Year Equity Growth Per Share -194.67 % 93.34 % 13.89 % 13.89 % 128.49 %
Share Holder 10 Year Equity Growth Per Share - 354.67 % 241.78 % 241.78 % 166.2 %
Dividend Per Share Growth - - -2.44 % -2.44 % 9.12 %
Dividend 3 Year Growth Per Share - - 4.79 % 4.79 % 23.08 %
Dividend 5 Year Growth Per Share - - 4.14 % 4.14 % 29.8 %
Dividend 10 Year Growth Per Share - - 74.3 % 74.3 % 91.97 %
Debt Growth 36.22 % - 26.65 % 26.65 % -44.68 %
Free Cash Flow Growth -92.04 % 73.93 % 45.25 % 45.25 % 130 %
Updated On 31 Dec 2024 31 Dec 2024 30 Sep 2024 30 Sep 2024 30 Jun 2024
Profitability
GCTK ISRG BDXA BDX ALC RMD
Gross Profit Margin TTM - 66.65 % 44.5 % 44.5 % 55.55 % 58.53 %
Return on Assets TTM -133.55 % 13.57 % 2.75 % 2.75 % 3.61 % 17.36 %
Return on Equity TTM 393.38 % 16.34 % 5.86 % 5.86 % 5.22 % 25.18 %
Return on Capital Employed TTM -345.6 % 14.89 % 5.05 % 5.05 % 5.26 % 24.33 %
Net Income Per EBT TTM 100 % 87.46 % 89.01 % 89.01 % 83.9 % 83.26 %
EBT Per Ebit TTM 48.48 % 113.2 % 71.19 % 71.19 % 88.24 % 97.84 %
EBIT Per Revenue TTM - 28.8 % 11.33 % 11.33 % 15.24 % 32.1 %
Cash Flow To Debt Ratio TTM -24013.46 % - 17.12 % 17.12 % 40.46 % 196.83 %
Receivables Turnover TTM - 6.78 6.89 6.89 5.34 5.53
Payables Turnover TTM 0.01 11.04 - - 5.24 9.36
Inventory Turnover TTM - 1.96 3.11 3.11 1.88 2.41
Fixed Asset Turnover TTM - 190.56 % 313.98 % 313.98 % 202.43 % 729.93 %
Asset Turnover TTM - 47.58 % 38.31 % 38.31 % 32.01 % 66.36 %
Operating Cash Flow Per Share TTM -33.58 7.62 11.44 11.44 4.24 11.27
Free Cash Flow Per Share TTM -33.72 4.87 8.98 8.98 3.26 10.66
Cash Per Share TTM 2446.83 % 1258.38 % 236.81 % 236.81 % 285.19 % 635.71 %
Operating Cash Flow Sales Ratio TTM - 29.87 % 15.81 % 15.81 % 21.17 % 32.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.43 % 63.9 % 78.51 % 78.51 % 76.82 % 94.64 %
Cash Flow Coverage Ratios TTM -24013.46 % - 17.12 % 17.12 % 40.46 % 196.83 %
Price To Free Cash Flows Ratio TTM -0.3 99.23 19.72 19.14 26.92 26.03
Price To Operating Cash Flows Ratio TTM -0.2 63.41 15.58 15.12 20.7 24.65
Price Cash Flow Ratio TTM -0.2 63.41 15.58 15.12 20.7 24.65
Income Statement (TTM)
GCTK ISRG BDXA BDX ALC RMD
Revenue $0B $8.35B $20.18B $20.18B $9.91B $5.15B
Gross Profit $0B $5.63B $9.13B $9.13B $5.51B $3.05B
Gross Profit Ratio 0% 67.46% 45.22% 45.22% 55.61% 59.36%
EBITDA $-0.02B $2.81B $4.82B $4.82B $2.68B $1.69B
Net Income $0.02B $2.32B $1.71B $1.71B $1.02B $1.4B
EPS Diluted 60.76 6.42 5.86 5.86 2.05 -
Balance Sheet (MRQ)
GCTK ISRG BDXA BDX ALC RMD
Long Term Debt $0B $0.11B $17.94B $17.94B $4.97B $0.84B
Total Liabilities $0.02B $2.31B $31.4B $31.4B $8.79B $2.01B
Total Equity $-0.01B $16.53B $25.89B $25.89B $21.55B $4.86B
Total Investments $0B $7.05B $0.45B $0.45B $0.91B $0.17B
Total Debt $0B $0.15B $20.11B $20.11B $5.14B $0.87B
Total Assets $0.01B $18.84B $57.29B $57.29B $30.35B $6.87B
Cash Flow Statement (TTM)
GCTK ISRG BDXA BDX ALC RMD
Net Income $-0.02B $2.34B $1.71B $1.71B $1.02B $1.4B
Inventory $0B $-0.83B $0.1B $0.1B $-0.05B $-0.08B
Dividends Paid $0B $0B $-1.1B $-1.1B $-0.13B $-0.31B
Operating Cash Flow $-0.01B $2.42B $3.8B $3.8B $2.08B $1.75B
Capital Expenditure $-0B $-1.11B $-0.73B $-0.73B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 87.87
ANGO AngioDynamics, Inc. 8.56
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 141.35
ATRC AtriCure, Inc. 34.41
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 32.34
BAX Baxter International Inc. 21.96
BDX Becton, Dickinson and Company 176.37
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 13.5
BLFS BioLife Solutions, Inc. 20.805
COO The Cooper Companies, Inc. 70.87
DXR Daxor Corporation 9.45
EKSO Ekso Bionics Holdings, Inc. 3.49
FEMY Femasys Inc. 0.8196
Unlock